Company Profile

Absci

Absci is a pioneering biotechnology company that leverages generative artificial intelligence (AI) for drug creation.

Headquarters

Vancouver, Washington, USA

Year Founded

2011

Top Impacted Industries

Pharmaceuticals, Biotechnology, Drug Discovery, Life Sciences, Healthcare

About Us

Absci is a generative AI drug creation company combining AI, proprietary biological data, and high-throughput wet-lab validation to design and optimize biologic drugs. Its platform uses generative AI for de novo antibody design, target discovery, and lead optimization, with applications across challenging therapeutic targets.

Related Articles

Trending Companies

Latest Articles

futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.

© 2026 All Rights Reserved.